SARAH KINTZ: Open Payments
NPI 1205338126 · KENDALLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 45 payments from 16 companies in 2025. Trend: 2023 $622 · 2024 $815 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $152 |
| AstraZeneca Pharmaceuticals LP | 6 | $114 |
| Lilly USA, LLC | 4 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Novo Nordisk Inc | 3 | $54 |
| PFIZER INC. | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
Products named: JARDIANCE, Kerendia, FARXIGA, VRAYLAR, QULIPTA, NURTEC ODT, BREZTRI, Wegovy.
Industry payments across IN — which companies pay providers there.
